Literature DB >> 76578

In vitro correlate of tranplantation immunity: spleen cell migration inhibition in the lizard, Calotes Versicolor.

S Jayaraman, V R Muthukkaruppan.   

Abstract

Sensitization to skin allografts in the lizard, Calotes versicolor, was assessed using the in vitro capillary migration inhibition (MI) assay. In the presence of the respective donor antigen, an appreciable degree of MI of sensitized spleen cells was observed as early as 4 days after grafting. A maximum level was attained on day 7 and this response was maintained as long as one month after grafting with only slight fluctuations in the level of MI. When the clinical manifestations of graft rejection culminated on day 35, the degree of MI was still at the maximum level. MI of allograft-sensitized spleen cells is an antigen specific event, and the same level of inhibition is observed whether the specific antigen is provided in the form of intact spleen cells or spleen extract.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 76578     DOI: 10.1016/s0145-305x(77)80006-2

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  3 in total

1.  Influence of route and dose of antigen on the migration inhibition and plaque-forming cell responses to sheep erythrocytes in the lizard, Calotes versicolor.

Authors:  S Jayaraman; V Muthukkaruppan
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

2.  Detection of cell-mediated immunity to sheep erythrocytes by the capillary migration inhibition technique in the lizard, Calotes versicolor.

Authors:  S Jayaraman; V Muthukkaruppan
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

3.  Transcriptome analysis of epigenetically modulated genome indicates signature genes in manifestation of type 1 diabetes and its prevention in NOD mice.

Authors:  Sundararajan Jayaraman; Akshay Patel; Arathi Jayaraman; Vasu Patel; Mark Holterman; Bellur Prabhakar
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.